Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jiexin Zhang has a total of 76 co-authors. Here are the top co-authors by number of shared publications:

  • Hua-Guo Xu

    Department of Laboratory Medicine, the First Affiliated Hospital with, Nanjing Medical University, Nanjing, China

    6 shared publications
  • Jian Xu

    Department of Laboratory Medicine, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China

    4 shared publications
  • Shichang Zhang

    Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, 210029 Nanjing, China

    4 shared publications
  • Mengyao Yu

    Department of Laboratory Medicine, The First Affiliated Hospital with Nanjing Medical University

    3 shared publications
  • Shi-Chang Zhang

    Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing 210029, Jiangsu, Peoples R China

    3 shared publications
  • Shichang Zhang

    Department of Laboratory Medicine, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China

    3 shared publications

Latest Publications

  • Open Access

    Strategies for the detection and prevention of human cytomegalovirus from pregnancy to the neonatal period

    by Pei Hu, Wenjie Chen, Ying Zhou, Mengyao Yu, Yuexinzi Jin, Xi Chen, Jiexin Zhang, Jin Zhou

    Human cytomegalovirus (HCMV) is a major cause of congenital infection worldwide. Maternal infection with HCMV during pregnancy may lead to adverse fetal outcomes and long-term sequelae of congenital infection. In this review, we summarized three specimen sources, their corresponding valid indicators, and mainstream detection methods. Prevention strategies administered based on the results of these tests aim to reduce the risks of maternal infection and maternal-fetal transmission and the development of complications following congenital infection through behavioral and hygiene-related interventions, vaccination, and hyperimmune globulin and antiviral agent administration. In this review, we presented a flowchart for full-process HCMV infection management, which covers three levels of prevention nodes, confirmatory tests at each level, and corresponding interventional approaches. Future efforts require support from the funding, institutional, and educational sectors to accelerate the development of sensitive and inexpensive methods for the rapid identification of potential biomarkers.

  • Ultrasound-induced cascade nanozyme catalysis for enhanced tumor cell pyroptosis and systemic anti-tumor immunity

    by Shuheng Qin, Mengchu Zhao, Weishu Gao, Ziqi Zhou, Yong Hu, Jiexin Zhang, Jian Xu


  • Open Access

    IgM–C4d Complex Causes the Inaccurate Measurement of Serum Uric Acid Levels via the Uricase Method

    by Yuexinzi Jin, Yuan Mu, Li Wang, Bingfeng Zhang, Suli Ge, Huaguo Xu, Jian Xu, Jiexin Zhang

    Accurate measurement of serum uric acid (UA) is critical for disease assessment and therapeutic monitoring; however, numerous factors can compromise the accuracy of UA detection. This study describes a novel circulating immunoglobulin M (IgM)-involved protein complex that interferes with the uricase method and reduces serum UA measurement accuracy. A total of 24 serum samples were collected from 18 patients, and complete clinical information and laboratory data were obtained. Samples were divided into three groups according to their UA reaction curves. Optical density values were extracted to analyze differential insoluble properties, serum viscosity was measured, coimmunoprecipitation was performed for IgM complex detection, and three additional clinical methodologies were used for UA measurement and comparison. All samples exhibiting unique reaction curves showed simultaneous elevations in IgM and complement component 4 (C4) levels. Circulating IgM formed a protein complex with C4d without significantly increasing serum viscosity. The insolubility of the IgM–C4d complex was attributable to the particular alkaline component of the uricase reagent. Inaccurate UA measurements could only be corrected by mass spectrometry. This study represents the first report of the circulating IgM–C4d protein complex. Given that serum UA serves as a crucial therapeutic indicator for specific patient populations, mass spectrometry is the preferred analytical method for accurate UA quantification in these individuals.

  • Open Access

    High serum unconjugated bilirubin levels following successful treatment of antiepileptic drug-induced bullosa epidermolysis: a case report and review of the literature

    by Chen Cheng, Yangyang Sun, Bingfeng Zhang, Huaguo Xu, Jian Xu, Jiexin Zhang

    Most of the classical antiepileptic drugs (AEDs) such as lamotrigine (LTG) and levetiracetam (LEV) are known to potentially cause skin lesions and liver injury. This paper reports an unusual phenomenon that serum levels of unconjugated bilirubin (IBIL) abnormally increased after the successful treatment of AED-induced bullosa epidermolysis, regardless of the presence of genetic mutations associated with hepatocellular bilirubin metabolism. A 14-year-old female, who was suffering from epilepsy, presented to our hospital with fever and red papules all over her body. Based on histopathological examination of the skin biopsy specimen and a medical history of LTG and LEV use, toxic epidermal necrolysis (TEN) was confirmed. After methylprednisolone treatment for 29 days, the skin lesions showed retreated but drug-induced liver injury (DILI) aggravated. Serum biochemical test results revealed elevated levels of serum total bilirubin, conjugated bilirubin, IBIL, gamma glutamyl transpeptidase, alkaline phosphatase, total cholesterol, and total bile acid. B-ultrasound examination indicated cholecystitis. The upper abdominal magnetic resonance cholangiopancreatography was performed four times on her and revealed progressive dilatation of the biliary ducts and cholestasis. A whole-exon sequencing of the liver biopsy specimen revealed a heterozygous 1249G>A mutation in the ATP binding cassette subfamily C member 2 gene and a heterozygous 211G>A mutation in the UDP glucuronosyltransferase family 1 member A1 gene. Hepatobiliary protection regimen was administered for a total of 71 days to reduce serum bilirubin level and to relieve symptoms. Nevertheless, the patient developed chronic DILI. The serum IBIL levels showed limited response to the regimen and instead increased to as high as 344.6 μmol/L. After taking phenobarbital, the IBIL level decreased only to 270.2 μmol/L. However, we documented a strong inverse correlation between serum creatine kinase (CK) and IBIL levels, which has not been discussed in other reported cases of AED-induced liver injury. This case emphasizes that the precise interpretation of serum hepatobiliary indexes is important for differentiating energy imbalance from organic integrity. A combination of serum CK and IBIL may serve as a useful laboratory tool for DILI stage assessment.


  • Open Access

    Tumor-Associated Macrophage in Breast Tumor Microenvironment

    by Lingyao Ma, Yuexinzi Jin, Jian Xu, Jiexin Zhang

    Breast cancer (BC) is the most common cancer in women worldwide. It is one of the main causes of cancer-related mortality. The breast tumor microenvironment (Br-TME) has emerged as an important factor related to BC development and prognosis. Tumor-associated macrophages (TAMs) are the main effector cells in the Br-TME; they play key roles in regulating angiogenesis, immunosuppression, metastasis, and chemoresistance in BC patients. In this review, we introduce the macrophage niche in the Br-TME, particularly emphasizing the origin of TAMs. Next, we summarize the typical pathways and molecular mechanisms of the interactions between TAMs and various other components in the Br-TME. Finally, we provide an overview of drugs that target TAMs and discuss the prevailing technologies for drug delivery in the context of BC treatment. Identification of the dynamic variations in tumor-promoting TAMs will help reveal the key links that drive BC progression. This review provides a theoretical basis for upcoming clinical trials that may substantially benefit patients.


  • Serum vitamin B12 levels during chemotherapy against diffuse large B-cell lymphoma: a case report and review of the literature

    by Fang Wang, Li Wei, Bingfeng Zhang, Zhen Ling, Jiexin Zhang

    Article Serum vitamin B12 levels during chemotherapy against diffuse large B-cell lymphoma: a case report and review of the literature was published on June 12, 2024 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 0, issue 0).

  • Open Access

    What makes SARS‐CoV‐2 unique? Focusing on the spike protein

    by Jingbo Qian, Shichang Zhang, Fang Wang, Jinming Li, Jiexin Zhang

    Severe acute respiratory syndrome‐related coronavirus 2 (SARS‐CoV‐2) seriously threatens public health and safety. Genetic variants determine the expression of SARS‐CoV‐2 structural proteins, which are associated with enhanced transmissibility, enhanced virulence, and immune escape. Vaccination is encouraged as a public health intervention, and different types of vaccines are used worldwide. However, new variants continue to emerge, especially the Omicron complex, and the neutralizing antibody responses are diminished significantly. In this review, we outlined the uniqueness of SARS‐CoV‐2 from three perspectives. First, we described the detailed structure of the spike (S) protein, which is highly susceptible to mutations and contributes to the distinct infection cycle of the virus. Second, we systematically summarized the immunoglobulin G epitopes of SARS‐CoV‐2 and highlighted the central role of the nonconserved regions of the S protein in adaptive immune escape. Third, we provided an overview of the vaccines targeting the S protein and discussed the impact of the nonconserved regions on vaccine effectiveness. The characterization and identification of the structure and genomic organization of SARS‐CoV‐2 will help elucidate its mechanisms of viral mutation and infection and provide a basis for the selection of optimal treatments. The leaps in advancements regarding improved diagnosis, targeted vaccines and therapeutic remedies provide sound evidence showing that scientific understanding, research, and technology evolved at the pace of the pandemic.


  • Open Access

    Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice

    by Chenyu Ma, Yuexinzi Jin, Yuhan Wang, Huaguo Xu, Jiexin Zhang

    Alpha-fetoprotein (AFP) is a commonly used clinical biomarker. Before 1970, the two-way agar diffusion method was mainly used, and the specificity of AFP in the diagnosis of primary liver cancer was satisfactory. However, its positivity rate was not very high. The diagnostic value of AFP is changing with the evolution of detection methods. Here, we performed a literature search to identify English-language publications. The search was performed from January 2015 to April 2023 using the PubMed database and the following terms in [Titles/Abstracts]: alpha-fetoprotein, clinical practice, detection, etc. The references of retrieved articles were also screened to broaden the search. Studies referring to liver cancer and AFP detection methods were excluded. In this review, several clinical application scenarios for AFP were systematically reviewed, and its potential detection value in the future was discussed.


  • Open Access

    Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis

    by Jin-Tong Shi, Nuo Chen, Jia Xu, Hemant Goyal, Zhi-Qi Wu, Jie-Xin Zhang, Hua-Guo Xu

    Fecal calprotectin (FC) levels correlate with the disease activity of inflammatory bowel diseases (IBD); however, the utility of FC in predicting IBD relapse remains to be determined. We aim to evaluate the efficacy of fecal calprotectin in predicting the relapse of inflammatory bowel disease. We searched Pubmed (MEDLINE), Embase, Web of Science, and the Cochrane library databases up to 7 July 2021. Our study estimated the pooled sensitivity and specificity, summary receiver operating characteristic (SROC) curve, and the optimal cut-off value for predicting IBD relapse using a multiple threshold model. A total of 24 prospective studies were included in the meta-analysis. The optimal FC cut-off value was 152 μg/g. The pooled sensitivity and specificity of FC was 0.720 (0.528 to 0.856) and 0.740 (0.618 to 0.834), respectively. FC is a useful, non-invasive, and inexpensive biomarker for the early prediction of IBD relapse. An FC value of 152 μg/g is an ideal threshold to identify patients with a high relapse probability.


  • Open Access

    Follow-up value of serum AFP and aminotransferases in chronic hepatitis B progression

    by Mengyao Yu, Lei Huang, Shichang Zhang, Longfeng Jiang, Yuexinzi Jin, Min Gu, Jun Liao, Jiexin Zhang

    Introduction: Chronic viral hepatitis (CH) is a stage prior to cirrhosis and primary cancer. Standard protocols for CH assessment during the long follow-up period are of great importance for precise treatment and living quality improvement. In this study, we aimed to analyze multiple serum indexes in chronic hepatitis B (CHB)-infected patients and to discuss their combined values in clinical applications.Methods: Total 503 lines of laboratory data from 2012 to 2021 were extracted from103 CHB patients who were followed-up in our hospital. They were divided into the remission group and the progression group according to their complete clinical information and laboratory data. A series of models of serum indexes were analyzed to illustrate the fluctuation trend of @ach index in a time-dependent manner.Results: The models revealed that abundant serum alpha-fetoprotein (AFP) in the remission group was characteristically associated with hepatocyte destruction markers aspartate aminotransferase (AST) and alanine aminotransferase and favored a much longer progression-free period (P 0.0001). A model-derived equation consisting of serum AFP and AST values showed a good performance (83% reliability) to distinguish the two groups.Discussion: This study clearly demonstrates the intrinsic quantitative relationship between serum AFP and liver aminotransferases involving antivirus treatment response. The model-based equation compensates for serum hepatitis B virus DNA detection during outpatient follow-up and it may serve as a useful laboratory tool for CHB progression assessment.